Format: 16 patches
Dimensions: 15 x 5 cm
Application: remove one of the two parts of the protective backing, apply the adhesive side of the patch to the skin, remove the other half of the protective backing and make the patch adhere to the epidermis.
Make sure the skin is clean and dry and that the scar is completely covered. If one patch is not sufficient to cover the entire area, another patch can be applied alongside it. For smaller scars, the patch can be cut to the desired size, as shown in the figure.
Kaloidon Patch is suitable for any part of the body, including the face. The patch should be replaced daily.
Patch removal: dab the skin around the patch with a sponge soaked in lukewarm water, or with a cotton pad, and lift one edge while continuing to wet the affected area. Remove it slowly.
(1) Conti V., Corbi G., Iannaccone T., Corrado B., Giugliano L., Lembo S., Filippelli A., & Guida M. (2020). Effectiveness and tolerability of a patch containing onion extract and allantoin for cesarean section scars. Frontiers in Pharmacology, 11, Article 569514.
(2) Campanati A., Ceccarelli G., Brisigotti V., Molinelli E., Martina E., Talevi D., Marconi B., Giannoni M., Markantoni V., Gregoriou S., Kontochristopoulos G., & Offidani A. (2021). Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study. Dermatologic Therapy, 34(1), e14665.
(3) Cosio, T.; Costanza, G.; Coniglione, F.; Romeo, A.; Iacovelli, F.; Diluvio, L.; Dika, E.; Shumak, R.G.; Rossi, P.; Bianchi, L.; et al. From In Silico Simulation between TGF-β Receptors and Quercetin to clinical Insight of a Medical Device Containing Allium cepa: Its Efficacy and Tolerability on Post-Surgical Scars. Life 2023, 13, 1781.
(4) Campanati A.; Savelli A.; Sandroni L.; Marconi B.; Giuliano A.; Giuliodori K.; Ganzetti G.; Offidani A. Effect of Allium Cepa-Allantoin-Pentaglycan Gel on skin Hypertrophic Scars: Clinical and Video-Capillaroscopic Results of an Opne-Label, Controlled, Nonrandomized Clinical Trial. Dermatologic Surgery, 2010; 36:1439-1444.
(5) Becker LC, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F. Final report of the safety assessment of allantoin and its related complexes. Int J Toxicol. 2010 May;29(3 Suppl):84S-97S. doi: 10.1177/1091581810362805. PMID: 20448269.